Smith L, Mosley J, Yates J, Caswell L. The New Face of Hyperlipidemia Management: Proprotein Convertase Subtilisin/Kexin Inhibitors (PCSK-9) and Their Emergent Role As An Alternative To Statin Therapy. J Pharm Pharm Sci [Internet]. 2016 Mar. 8 [cited 2025 Apr. 3];19(1):137-46. Available from: https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/25981